转移淋巴结比率在预测甲状腺髓样癌癌症特异性生存方面优于淋巴结转移数目和TNM/AJCC N分期
该研究在三级中心对505例甲状腺髓样癌患者行术后Kaplan-Meier癌症特异性生存分析,比较转移淋巴结比率(MLNR)、淋巴结转移数目和TNM/AJCC N分类的预测能力。按MLNR(以0.20递增)分层时生存曲线分离最大,其次为淋巴结转移数目(以10枚和20枚递增)和TNM/AJCC分类。合并重叠生存曲线后,MLNR≤0.20 vs 0.21-0.60 vs >0.60、0 vs 1-20 vs >20枚淋巴结转移、N0/N1a vs N1b各组相邻曲线间均存在显著差异。结论认为MLNR反映淋巴播散强度,对癌症特异性生存的预测优于淋巴结转移数目或TNM/AJCC N分类。
要点
- 在505例甲状腺髓样癌患者中,按转移淋巴结比率(MLNR,以0.20递增)分层时生存曲线分离最大。
- MLNR≤0.20 vs 0.21-0.60 vs >0.60相邻组间癌症特异性生存均存在显著差异。
- 0 vs 1-20 vs >20枚淋巴结转移相邻组间及N0/N1a vs N1b间癌症特异性生存均存在显著差异。
核心结论
- 在甲状腺髓样癌中,转移淋巴结比率反映淋巴播散强度,对癌症特异性生存的预测优于淋巴结转移数目或TNM/AJCC N分类。
研究设计与样本
- 对三级中心手术后505例甲状腺髓样癌患者进行癌症特异性生存的Kaplan-Meier分析。
主要发现
- 按转移淋巴结比率(以0.20递增)分层时生存曲线分离最大,其次为淋巴结转移数目(以10枚和20枚递增)和TNM/AJCC分类(N0、N1a、N1b)。
- 合并重叠生存曲线后,MLNR≤0.20 vs 0.21-0.60 vs >0.60各组相邻曲线间癌症特异性生存均存在显著差异。
- 合并重叠生存曲线后,0 vs 1-20 vs >20枚淋巴结转移各组相邻曲线间癌症特异性生存均存在显著差异。
- 合并重叠生存曲线后,TNM/AJCC N分类N0/N1a vs N1b间癌症特异性生存存在显著差异。
临床怎么用
- 作者认为,在甲状腺髓样癌中转移淋巴结比率对癌症特异性生存的预测优于淋巴结转移数目或TNM/AJCC N分类。
- 作者指出,这些发现对颈部淋巴结清扫范围有限患者的适用性需要更多研究。
局限性
- 作者指出,这些发现对颈部淋巴结清扫范围有限患者的适用性需要更多研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In medullary thyroid cancer (MTC), it is unclear which nodal classification system, metastatic lymph node ratio (MLNR), number of node metastases, or TNM/AJCC N classification, predicts cancer-specific survival best. METHODS: Kaplan-Maier analysis of cancer-specific survival after operation at a tertiary center. RESULTS: Included were 505 MTC patients. The spread of the survival curves was greatest after stratification by MLNR (in 0.20 increments), followed by number of node metastases (in 10-node and 20-node increments) and TNM/AJCC classification (N0, N1a, N1b). After collapsing overlapping survival curves, all adjacent curves (MLNRs ≤0.20 vs. 0.21-0.60 vs. >0.60; 0 vs. 1-20 vs. >20 node metastases; and TNM/AJCC N classification N0/N1a vs. N1b) significantly differed between each other. CONCLUSIONS: In MTC, MLNR, reflecting intensity of lymphatic spread, predicts cancer-specific survival better than number of node metastases or TNM/AJCC N classification. The applicability of these findings to patients with limited neck dissection requires more research.
引用
- Machens A, Lorenz K, Weber F, et al. Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer. Head Neck. 2022. PMID: 36065717. doi:10.1002/hed.27181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。